Vitiligo: vizsgálatok itt: Japán
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
- Where
- Kofu, Nagoya, Niigata, Shinjuku Ku, Urayasu
- Életkor
- 18 év to 99 év
- People
- 210 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07431177 · EU 2025-522301-37-00